JP2014527816A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527816A5
JP2014527816A5 JP2014530760A JP2014530760A JP2014527816A5 JP 2014527816 A5 JP2014527816 A5 JP 2014527816A5 JP 2014530760 A JP2014530760 A JP 2014530760A JP 2014530760 A JP2014530760 A JP 2014530760A JP 2014527816 A5 JP2014527816 A5 JP 2014527816A5
Authority
JP
Japan
Prior art keywords
patient
level
levels
gene
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014530760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014527816A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054914 external-priority patent/WO2013040071A2/en
Publication of JP2014527816A publication Critical patent/JP2014527816A/ja
Publication of JP2014527816A5 publication Critical patent/JP2014527816A5/ja
Pending legal-status Critical Current

Links

JP2014530760A 2011-09-15 2012-09-12 初期卵巣がんの検出マーカーとしての精子タンパク質 Pending JP2014527816A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161535309P 2011-09-15 2011-09-15
US61/535,309 2011-09-15
PCT/US2012/054914 WO2013040071A2 (en) 2011-09-15 2012-09-12 Sperm protein as a detection biomarker of early stage ovarian cancer

Publications (2)

Publication Number Publication Date
JP2014527816A JP2014527816A (ja) 2014-10-23
JP2014527816A5 true JP2014527816A5 (enExample) 2015-11-05

Family

ID=47883948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530760A Pending JP2014527816A (ja) 2011-09-15 2012-09-12 初期卵巣がんの検出マーカーとしての精子タンパク質

Country Status (7)

Country Link
US (1) US20150110897A1 (enExample)
EP (1) EP2756100A4 (enExample)
JP (1) JP2014527816A (enExample)
CN (1) CN104039980A (enExample)
CA (1) CA2848578A1 (enExample)
IN (1) IN2014CN02496A (enExample)
WO (1) WO2013040071A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104807997A (zh) * 2015-05-05 2015-07-29 南京格耀生物科技有限公司 一种基于化学发光法检测ca125和sp17含量的试剂盒及方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306600A1 (en) * 2001-02-26 2002-09-12 Albany Medical College Sperm protein 17 for the diagnosis and treatment of cancer
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AT501348B1 (de) * 2005-01-31 2008-10-15 Vitateq Biotechnology Gmbh Verfahren zur tumordiagnose
CN100334110C (zh) * 2005-09-01 2007-08-29 中国人民解放军南京军区南京总医院 一种精子蛋白单克隆抗体及其制备方法和用途
DE602006015508D1 (de) * 2005-11-16 2010-08-26 Pantarhei Bioscience Bv Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs

Similar Documents

Publication Publication Date Title
Pant et al. A principal component regression based genome wide analysis approach reveals the presence of a novel QTL on BTA7 for MAP resistance in holstein cattle
Hudgins et al. Age-and tissue-specific expression of senescence biomarkers in mice
JP2017516458A5 (enExample)
Ha et al. The circadian rhythm gene Arntl2 is a metastasis susceptibility gene for estrogen receptor-negative breast cancer
CN109937452B (zh) 免疫疗法标志及其用途
JP2017514813A5 (enExample)
RU2017146409A (ru) Способы прогнозирования рака предстательной железы
WO2013182912A4 (en) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
Espeso-Gil et al. Environmental enrichment induces epigenomic and genome organization changes relevant for cognition
JP2015523569A5 (enExample)
JP2020535827A (ja) マイクロrna遺伝子発現を使用して黒色腫を診断し、病期分類し、モニタリングする方法
Qin et al. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease
JP2018527886A5 (enExample)
Puente et al. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
Menard et al. Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding and noncoding signatures in the presence and absence of MyD88
HRP20150948T1 (hr) Biomarkeri za procjenjivanje perifernog neuropatskog odgovora na lijeäśenje sa inhibitorom proteazoma
Pacholewska et al. The transcriptome of equine peripheral blood mononuclear cells
Haapasalo et al. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas
Ariel et al. Genome-wide association analysis identified both RNA-seq and DNA variants associated to paratuberculosis in Canadian Holstein cattle ‘in vitro’experimentally infected macrophages
Ruiz-Uribe et al. Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimer’s disease
US20160162635A1 (en) Method and system for determining a bacterial resistance to an antibiotic drug
JP2019533987A5 (enExample)
Cooke et al. Effects of a simulated wolf encounter on brain and blood biomarkers of stress-related psychological disorders in beef cows with or without previous exposure to wolves
JP2014527816A5 (enExample)
Chen et al. Serum aca-mir-146a is a potential biomarker for early diagnosis of Angiostrongylus cantonensis infection